• Mutation; HGNC; 11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Unspecified (PubMed=12794755).
  

PubMed=6208122; DOI=10.1089/hyb.1.1982.1.139
Anger B.R., Lloyd K.O., Oettgen H.F., Old L.J.
Mouse monoclonal IgM antibody against human lung cancer line SK-LC-3 with specificity for H(O) blood group antigen.
Hybridoma 1:139-147(1982)

PubMed=7116286; DOI=10.1002/1097-0142(19821015)50:8<1518::AID-CNCR2820500812>3.0.CO;2-R
Anger B.R., Bockman R.S., Andreeff M., Erlandson R.A., Jhanwar S.C., Kameya T., Saigo P.E., Wright W., Beattie E.J. Jr., Oettgen H.F., Old L.J.
Characterization of two newly established human cell lines from patients with large-cell anaplastic lung carcinoma.
Cancer 50:1518-1529(1982)

PubMed=6582512; DOI=10.1073/pnas.81.2.568; PMCID=PMC344720
Mattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O.
Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=2535957
Linkhart T.A., Mohan S., Jennings J.C., Baylink D.J.
Copurification of osteolytic and transforming growth factor beta activities produced by human lung tumor cells associated with humoral hypercalcemia of malignancy.
Cancer Res. 49:271-278(1989)

PubMed=8384671; DOI=10.1093/oxfordjournals.jjco.a039602
Hida T., Ariyoshi Y., Kuwabara M., Sugiura T., Takahashi T., Takahashi T., Hosoda K., Niitsu Y., Ueda R.
Glutathione S-transferase pi levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity.
Jpn. J. Clin. Oncol. 23:14-19(1993)

PubMed=12794755; DOI=10.1002/ijc.11184
Endoh H., Yatabe Y., Shimizu S., Tajima K., Kuwano H., Takahashi T., Mitsudomi T.
RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.
Int. J. Cancer 106:45-51(2003)